Results 71 to 80 of about 20,118 (262)

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner   +14 more
wiley   +1 more source

A Rare Case of Upper Tract Urothelial Carcinoma with Renal Calculi in a Horseshoe Kidney [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Upper Tract Urothelial Carcinomas (UTUCs) are rare renal tumours. A 42-year-old male presented with haematuria and left flank pain, and was diagnosed with multiple left renal calculi in a horseshoe kidney with a left partial duplex system on Computed ...
Sunil Mhaske   +3 more
doaj   +1 more source

Evaluation of a novel EHR sidecar application to display RA clinical outcomes during clinic visits: results of a stepped‐wedge cluster randomized pragmatic trial

open access: yesArthritis Care &Research, Accepted Article.
Objective We developed a novel EHR sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk   +16 more
wiley   +1 more source

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY

open access: yesArthritis Care &Research, Accepted Article.
Objective Mycophenolate Mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon due to the lower fibrotic burden and the predominance of the vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis   +77 more
wiley   +1 more source

Exploring the therapeutic potential of Madhuca longifolia in traditional Chinese medicine for the management of kidney stones and various diseases: A review

open access: yesPharmacological Research - Modern Chinese Medicine
Introduction: Kidney stones (renal calculi), are a common urological problem affecting millions worldwide. Madhuca longifolia (M. longifolia), commonly known as Mahua, has a rich history of medicinal use in various traditional systems, including ...
Dilip Kumar Chanchal   +1 more
doaj   +1 more source

Differential Item Functioning on the Patient Health Questionnaire 8 by Disease Subtype, Language, Sex, and Age Among People With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

open access: yesArthritis Care &Research, EarlyView.
Objective Somatic items used in depression assessments can potentially overlap with symptoms related to physical illness, including systemic sclerosis (SSc). No studies have looked at whether somatic depression items may be influenced by diffuse versus limited SSc disease subtypes, which are associated with varying degrees of symptom presentation.
Sophie Hu   +110 more
wiley   +1 more source

Bilateral infectious urolithiasis as a risk factor for acute kidney failure in a 3-year-old boy

open access: yesPediatria Polska
Infectious urolithiasis is a relatively rare form of urolithiasis in children. The predisposing factors in the pediatric population mainly include urinary tract defects and neurogenic bladder.
Karina Madej-Świątkowska   +7 more
doaj   +1 more source

Squamous Cell Carcinoma of Renal Pelvis - A Case Report

open access: yesJK Science, 2023
Squamous cell carcinoma of kidney is an extremely rare entity comprising for only 0.5-0.8% of malignant renal tumours. This also makes about 0.5%-1 % of all urothelial malignancies.
Bharti Thaker, Subhash Bhardwaj
doaj  

Home - About - Disclaimer - Privacy